| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Chronic etoposide schedules in the treatment of non-Hodgkin's lymphoma
|
Hainsworth, John D.
|
|
1992
|
19 |
6S14 |
p. 13-18
6 p.
|
artikel
|
| 2 |
Chronic oral etoposide in the treatment of lung cancer
|
DeVore, Russell
|
|
1992
|
19 |
6S14 |
p. 28-35
8 p.
|
artikel
|
| 3 |
Chronic oral etoposide: Trials at Indiana University and with the Hoosier Oncology Group
|
Loehrer Sr, Patrick J.
|
|
1992
|
19 |
6S14 |
p. 48-52
5 p.
|
artikel
|
| 4 |
Combination chemotherapy with oral etoposide
|
Johnson, David H.
|
|
1992
|
19 |
6S14 |
p. 19-24
6 p.
|
artikel
|
| 5 |
Etoposide in the treatment of hormone-refractory advanced carcinoma of the prostate
|
Crawford, E.David
|
|
1992
|
19 |
6S14 |
p. 53-57
5 p.
|
artikel
|
| 6 |
Etoposide: Seeking the best dose and schedule
|
Greco, F.Anthony
|
|
1992
|
19 |
6S14 |
p. 59-63
5 p.
|
artikel
|
| 7 |
Evaluation of oral etoposide in patients with metastatic gastric carcinoma: A preliminary report
|
Ajani, Jaffer A.
|
|
1992
|
19 |
6S14 |
p. 45-47
3 p.
|
artikel
|
| 8 |
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: Is there a role for this “new drug” in the management of platinum-refractory disease?
|
Markman, Maurie
|
|
1992
|
19 |
6S14 |
p. 25-27
3 p.
|
artikel
|
| 9 |
Oral etoposide in small cell lung cancer
|
Carney, Desmond N.
|
|
1992
|
19 |
6S14 |
p. 40-44
5 p.
|
artikel
|
| 10 |
Reimbursement for oral anticancer drugs
|
Bailes, Joseph S.
|
|
1992
|
19 |
6S14 |
p. 58-
1 p.
|
artikel
|
| 11 |
The activity of 10-, 14-, and 21-day schedules of single-agent etoposide in previously untreated patients with extensive small cell lung cancer
|
Clark, Peter I.
|
|
1992
|
19 |
6S14 |
p. 36-39
4 p.
|
artikel
|
| 12 |
What is the optimal dose and duration of treatment with etoposide? II. Comparative pharmacokinetic study of three schedules: 1 × 100 mg, 2 × 50 mg, and 4 × 25 mg of oral etoposide daily for 21 days
|
van der Gaast, Ate
|
|
1992
|
19 |
6S14 |
p. 8-12
5 p.
|
artikel
|
| 13 |
What is the optimal dose and duration of treatment with etoposide? I. Maximum tolerated duration of daily treatment with 50, 75, and 100 mg of oral etoposide
|
Splinter, Ted A.W.
|
|
1992
|
19 |
6S14 |
p. 1-7
7 p.
|
artikel
|
Tijdschrift beschrijving